hsa-miR-663b

ncRNA information

ncRNA name

hsa-miR-663b

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

TP73

Cancer information

Cancer name

Breast Cancer

Cancer site

Breast

Treatment information

Treatment type

Chemotherapy

Drug

Tamoxifen

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

It was identified that downregulation of miRNA-663b inhibited cell proliferation ability and promoted cell apoptosis, resulting in enhanced TAM sensitivity.

Tissue resource

human breast cancer tissues with tamoxifen resistance and the control tissues

human breast cancer cell line MCF7

tamoxifen resistant breast cancer cell line MCF7/TAM

Experiment

qRT-PCR,Western blot,Dual-luciferase reporter assay


Institute

The Third Affiliated Hospital of Sun Yat-sen University

American Type Culture Collection

Country

China

USA

Continent

Asia

North American